903557-48-2

Basic information

• Product Name: 5-BROMO-4-METHYL-2,3-DIHYDRO-1H-INDEN-1-ONE
• Synonyms: 5-BROMO-4-METHYL-2,3-DIHYDRO-1H-INDEN-1-ONE;5-Bromo-4-methyl-indan-1-one;5-bromo-4-methyl-2,3-dihydroinden-1-one
• CAS NO: 903557-48-2
• Molecular Formula: C10H9BrO
• Molecular Weight: 225.08186
• Mol File: 903557-48-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-BROMO-4-METHYL-2,3-DIHYDRO-1H-INDEN-1-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-4-METHYL-2,3-DIHYDRO-1H-INDEN-1-ONE(903557-48-2)
• EPA Substance Registry System: 5-BROMO-4-METHYL-2,3-DIHYDRO-1H-INDEN-1-ONE(903557-48-2)

Safety Data

• Hazardous Substances Data: 903557-48-2(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
5-BROMO-4-METHYL-2,3-DIHYDRO-1H-INDEN-1-ONE is used as a building block in the synthesis of other organic compounds. Its unique structure allows it to be a versatile intermediate in various chemical reactions, contributing to the development of new organic compounds with diverse applications.
Used in Pharmaceutical Applications:
In the pharmaceutical industry, 5-BROMO-4-METHYL-2,3-DIHYDRO-1H-INDEN-1-ONE is used as a key intermediate in the development of new drugs. Its unique structure and properties make it a promising candidate for the synthesis of pharmaceutical compounds with potential therapeutic effects.
Used in Medicinal and Biological Research:
5-BROMO-4-METHYL-2,3-DIHYDRO-1H-INDEN-1-ONE is also utilized in medicinal and biological research. Its distinctive structure and properties provide opportunities for exploring its potential in various research areas, including drug discovery and development, as well as understanding its interactions with biological systems.

Upstream product

• 903557-47-1 C₁₀H₁₁BrO₂ 
• 1030017-66-3 C₁₀H₁₀BrClO 

Relevant articles and documents

HETEROBICYCLIC METALLOPROTEASE INHIBITORS

The present invention relates generally to heterobicyclic containing pharmaceutical agents, and in particular, to heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic metalloprotease inhibiting compounds that exhibit an increased potency in relation to currently known metalloprotease inhibitors.

METALLOPROTEASE INHIBITORS

The present invention relates to amide containing aromatic MMP inhibiting compounds with a mono-amide heteroaromatic group, of formulas I and II:

HETEROBICYCLIC METALLOPROTEASE INHIBITORS

The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP- 13 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP- 13 inhibitors.

Multicyclic bis-amide MMP inhibitors

The present invention relates generally to bis-amide group containing pharmaceutical agents, and in particular, to multicyclic bis-amide MMP-13 inhibitor compounds. More particularly, the present invention provides a new class of MMP-13 inhibiting compounds, containing a pyrimidinyl bis-amide group in combination with a heterocyclic moiety, that exhibit an increased potency and solubility in relation to currently known bis-amide group containing MMP-13 inhibitors.